Reduction in NO levels causes platelet aggregation and reduced fibrinolysis by inhibiting tissue-type plasminogen activator (t-PA) [17,18], which could be a possible explanation for the increased incidence of ischemic stroke in COVID-19 subjects. Here, PLAT is linked to ischemic stroke.